Skip Page Header

Home > EMCDDA technical report on the new psychoactive substance methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA).

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2020) EMCDDA technical report on the new psychoactive substance methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA). Lisbon: EMCDDA.

[img]
Preview
PDF ((MDMB-4en-PINACA)
1MB

The purpose of this technical report is to provide an analysis of the available information on methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (commonly known as MDMB-4en-PINACA), a synthetic cannabinoid receptor agonist that has recently emerged on the drug market in Europe, in order to support the risk assessment of the substance which has been requested by the European Commission in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended).

Explanatory note: In the interests of public health protection the EMCDDA is releasing this report before formal copy editing and page layout in the EMCDDA house style. The final report will be available in due course.

Item Type
Report
Publication Type
Irish-related, International, Report
Drug Type
Cannabis, New psychoactive substance
Date
December 2020
Pages
53 p.
Publisher
EMCDDA
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction, Europol
Place of Publication
Lisbon
EndNote
Related URLs

Repository Staff Only: item control page